Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Jul 15.

Published in final edited form as: AIDS. 2010 Jan 16;24(2):163–187. doi: 10.1097/QAD.0b013e32833424c8

Table 5. Studies on HIV DNA in cervicovaginal secretions.

Study	HIV DNA

	Prevalence	Copy number^d

		Median	Range
Iverson et al. [142]	20/28 (71%)^a,^b,^c	NA	ND to 95
Panther et al. [140]	7/7 (100%)^b,^g ^*	3000^e ^*	ND to 24000^e
Panther et al. [140]	9/17 (53%)^b,^h ^*	300^e ^*	ND to 60000^e
Debiaggi et al. [143]	41/128 (32%)^b,^c	28	ND to 500
Spinillo et al. [131]	61/122 (50%)^a,^b,^c	48	ND to 1500
Andreoletti et al. [145]	20/30 (67%)^a	7	ND to 925
Tuomala et al. [7]	18/25 (72%)^a,^b,^g ^*	20^e ^*	ND to 10202^e
Tuomala et al. [7]	22/51 (43%)^a,^b,^h ^*	ND^*	ND to 40074^e
Zara et al. [146]	46/60 (77%)^a,^b,^c	69^f	ND to 500
Benki et al. [144]	16/26 (62%)^a,ⁱ	40	ND to 2220
Benki et al. [144]	6/26 (23%)^a,^j	ND	ND to 340

NA, not available; ND, not detectable.

^a

No ART.

^b

ART.

^c

HAART.

^d

Per 10⁵ cells or μg DNA unless noted.

^e

Per lavage.

^f

Mean.

^g

Pregnant women who transmitted HIV to their infants.

^h

Pregnant women who did not transmit HIV to their infants.

ⁱ

Endocervical secretions.

^j

Vaginal secretions.

^*

Significantly different, P <0.05.